About Arpeggi
Arpeggi is a Healthcare company based in Austin (United States) founded in 2012, and was acquired by Gene by Gene in August 2013. Genome sequencing solutions are developed for medical and life sciences. Arpeggi has raised $195 thousand across 1 funding round from investors including Gene by Gene. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its legal entity is Arpeggi Inc. Its competitors include Ancestry, Caribou Biosciences and Personalis; 3 of its 3 listed competitors have raised funding.
Company details
Arpeggi was founded in 2012 in Austin, United States. Solutions for genome sequencing services are provided to the medical and life sciences sectors. Genome sequencing, data management, and computational analysis are offered, along with sequence development, genome reconstruction, mutation detection, and pathway analysis for genetic data and samples. Operations focus on supporting research and applications in genetics.
- Headquarters Austin, United States
- Stage Acquired
- SectorsHealthcare
- Website arpeggi.com
- Social LinkedIn X
- Acquired by Gene by Gene (Aug 2013)
- Legal Name Arpeggi Inc
- Total Equity Funding$195K (USD)
in 1 rounds
- Latest Funding Round$195K (USD), Seed
Jan 2013
- Investors
- Acquired byGene by Gene
(Aug 2013)
Funding Insights of Arpeggi
Arpeggi has successfully raised a total of $195K through 1 strategic funding round. The most recent funding activity was a Seed round of $195 thousand completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $195,000
- Total Rounds 1
- Last Round Seed — $195,000
- First Round $195,000
(Jan 2013)
All 1 funding rounds of Arpeggi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $195,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Arpeggi
Arpeggi has secured backing from 1 investor. Prominent investors backing the company include Gene by Gene.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
DNA testing for ancestry, genealogy, and health is offered. | 2000 | genebygene.com | Houston, United States |
Investor details for Arpeggi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Arpeggi
3 dated milestones of Arpeggi across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Arpeggi is founded.
- Funding First funding round of $195K.
- Exit Acquired by Gene by Gene.
Competitors of Arpeggi
Arpeggi has 3 listed competitors in our database, 3 of them funded. They include Ancestry, Caribou Biosciences and Personalis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ancestry.com | 1996 | Lehi, United States | $146.2M | 1,228 | Provider of an online genealogy platform offering a host of services | |
| cariboubio.com | 2011 | Berkeley, United States | $156.55M | 92 | Provider of cell therapies to treat cancer and hematologic conditions | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. |
Detailed competitors of Arpeggi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Arpeggi (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Arpeggi
Arpeggi was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Arpeggi is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Arpeggi is a funded company, having raised a total of $195K across 1 funding round to date. The company's 1st funding round was a Seed of $195K, raised on Jan 2013.
Arpeggi was founded in 2012 in Austin, United States. Solutions for genome sequencing services are provided to the medical and life sciences sectors. Genome sequencing, data management, and computational analysis are offered, along with sequence development, genome reconstruction, mutation detection, and pathway analysis for genetic data and samples. Operations focus on supporting research and applications in genetics.
Arpeggi's top competitors include Ancestry, Personalis and Caribou Biosciences.
Arpeggi has 1 investor. Key investors include Gene by Gene.
Arpeggi operates through Arpeggi Inc.
Yes. Arpeggi was acquired by Gene by Gene in August 2013.